Bruce L. Gilliam
- Infectious Diseases top 2%
- Epidemiology top 5%
- Virology top 1%
- Pharmacology top 5%
- Molecular Medicine top 5%
- Co-authors
- David J. RiedelRobert RedfieldRohit TalwaniSusan A. FiscusJohn R. DyerMyron S. CohenJoseph J. EronManhattan Charurat
- Topics
- HIV Research and Treatment (25 papers)HIV/AIDS Research and Interventions (18 papers)HIV/AIDS drug development and treatment (17 papers)
- Partner nations
- United StatesNigeriaThailand
In The Last Decade
Bruce L. Gilliam
56 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Infectious Diseases 744
- Epidemiology 540
- Virology 498
- Pharmacology 207
- Molecular Medicine 157
Countries citing papers authored by Bruce L. Gilliam
This map shows the geographic impact of Bruce L. Gilliam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce L. Gilliam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce L. Gilliam more than expected).
Fields of papers citing papers by Bruce L. Gilliam
This network shows the impact of papers produced by Bruce L. Gilliam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce L. Gilliam. The network helps show where Bruce L. Gilliam may publish in the future.
Co-authorship network of co-authors of Bruce L. Gilliam
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce L. Gilliam. A scholar is included among the top collaborators of Bruce L. Gilliam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce L. Gilliam. Bruce L. Gilliam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 25 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 15 | |
| 8 | 14 | |
| 9 | 23 | |
| 10 | 7 | |
| 11 | 2 | |
| 12 | 28 | |
| 13 | 4 | |
| 14 | 9 | |
| 15 | 9 | |
| 16 | 1 | |
| 17 | 18 | |
| 18 | 112 | |
| 19 | 47 | |
| 20 | 95 |
About Bruce L. Gilliam
Bruce L. Gilliam is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (18 papers) and HIV/AIDS drug development and treatment (17 papers). The work is most often cited by research in Virology (498 citations), Infectious Diseases (744 citations) and Molecular Medicine (157 citations). Bruce L. Gilliam has collaborated with scholars based in United States, Nigeria and Thailand. Frequent co-authors include David J. Riedel, Robert Redfield, Rohit Talwani, Susan A. Fiscus, John R. Dyer, Myron S. Cohen, Joseph J. Eron, Manhattan Charurat, Sharon Wilson and Pietro Vernazza. Their work appears in journals such as Clinical Infectious Diseases, Journal of Virology and The American Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.